EP1173165A4 - Cardiovascular and bone treatment using isoflavones - Google Patents

Cardiovascular and bone treatment using isoflavones

Info

Publication number
EP1173165A4
EP1173165A4 EP00920267A EP00920267A EP1173165A4 EP 1173165 A4 EP1173165 A4 EP 1173165A4 EP 00920267 A EP00920267 A EP 00920267A EP 00920267 A EP00920267 A EP 00920267A EP 1173165 A4 EP1173165 A4 EP 1173165A4
Authority
EP
European Patent Office
Prior art keywords
isoflavones
cardiovascular
bone treatment
bone
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00920267A
Other languages
German (de)
French (fr)
Other versions
EP1173165A1 (en
Inventor
Graham Edmund Kelly
Alan James Husband
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kazia Research Pty Ltd
Original Assignee
Novogen Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Research Pty Ltd filed Critical Novogen Research Pty Ltd
Publication of EP1173165A1 publication Critical patent/EP1173165A1/en
Publication of EP1173165A4 publication Critical patent/EP1173165A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP00920267A 1999-04-28 2000-04-27 Cardiovascular and bone treatment using isoflavones Withdrawn EP1173165A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ0083A AUPQ008399A0 (en) 1999-04-28 1999-04-28 Cariovascular applications
AUPQ008399 1999-04-28
PCT/AU2000/000384 WO2000064438A1 (en) 1999-04-28 2000-04-27 Cardiovascular and bone treatment using isoflavones

Publications (2)

Publication Number Publication Date
EP1173165A1 EP1173165A1 (en) 2002-01-23
EP1173165A4 true EP1173165A4 (en) 2004-05-12

Family

ID=3814286

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00920267A Withdrawn EP1173165A4 (en) 1999-04-28 2000-04-27 Cardiovascular and bone treatment using isoflavones

Country Status (7)

Country Link
EP (1) EP1173165A4 (en)
JP (1) JP2002542286A (en)
AU (1) AUPQ008399A0 (en)
CA (1) CA2370553A1 (en)
HK (1) HK1043546A1 (en)
NZ (1) NZ513328A (en)
WO (1) WO2000064438A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ008299A0 (en) 1999-04-30 1999-05-27 G.J. Consultants Pty Ltd Isoflavone metabolites
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
EP1368024A4 (en) * 2001-03-16 2009-03-18 Novogen Res Pty Ltd Treatment of restenosis
AU2008200518B2 (en) * 2001-03-16 2010-04-01 Novogen Research Pty Ltd Treatment of restenosis
JP5060691B2 (en) * 2001-07-09 2012-10-31 雪印メグミルク株式会社 Nutritional composition
DE10151363A1 (en) * 2001-10-17 2003-05-08 Schering Ag Use of estrogen receptor beta agonists to prepare medicaments for producing somatotropic and organotropic effects on the CNS, circulatory, skeletal and immune system in aging men and women
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
JP5384777B2 (en) * 2001-12-18 2014-01-08 有限会社大長企画 Strong muscle agent, anti-inflammatory agent
CA2539029C (en) 2003-09-19 2011-05-03 Sunstar Inc. Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
JP2009536610A (en) * 2006-02-28 2009-10-15 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ Pharmaceutical composition for the prevention / treatment of bone disease and preparation method thereof
PL1988891T3 (en) * 2006-02-28 2017-05-31 Nestec S.A. Compositions and methods for inducing bone growth and inhibiting bone loss
US8680140B2 (en) 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
WO2008016768A1 (en) * 2006-08-02 2008-02-07 Roberta Diaz Brinton Phytoestrogenic formulations and uses thereof
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
WO2008146835A1 (en) * 2007-05-28 2008-12-04 Fuji Oil Company, Limited Composition for promoting equol production in the blood of subject unable to produce equol
WO2013050930A1 (en) * 2011-10-02 2013-04-11 Sinoveda Canada, Inc, Development of a red clover phytoestrogen product for the prevention or treatment of osteoporosis
US9333192B2 (en) 2010-02-15 2016-05-10 Sinoveda Canada, Inc Phytoestrogen product of red clover and pharmaceutical uses thereof
RU2552300C2 (en) * 2013-10-23 2015-06-10 Государственное бюджетное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Минздрава Российской Федерации Method for correcting bone tissue status and preventing fractures in cardiovascular patients
JP6781427B2 (en) * 2016-05-24 2020-11-04 学校法人日本大学 Tooth relapse inhibitor containing daidzein as an active ingredient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656786B2 (en) * 1992-05-19 2014-04-23 Novogen Research Pty Ltd Use of isoflavone phyto-oestrogen extracts of soy or clover
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
JPH10114653A (en) * 1996-10-11 1998-05-06 Taishi Shokuhin Kogyo Kk Composition for promoting osteogenesis and preventing bone salt mass from reducing
DE19650777A1 (en) * 1996-12-06 1998-06-10 Meto International Gmbh Method and device for producing deactivatable security elements
EP0979074A4 (en) * 1997-05-01 2003-07-09 Novogen Inc Treatment or prevention of menopausal symptoms and osteoporosis
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Novogen launches Rimostil", XP002273344, Retrieved from the Internet <URL:http://www.novogen.com/news/news0502.cfm?mainsection=05&subsection=02&newsid=22> [retrieved on 20040311] *
BABER R: "The effect of an isoflavone dietary supplement (Rimostil) on serum lipids, forearm bone density and endometrial thickness in post-menopausal women", PROCEEDINGS OF THE 10TH ANNUAL MEETING OF TEH NORTH AMERICAN MENOPAUSE SOCIETY, 23 September 1999 (1999-09-23), NEW YORK, XP002273343, Retrieved from the Internet <URL:http://www.rimostil.com/uploads/rimostil_clincal_study.pdf> [retrieved on 20040311] *
See also references of WO0064438A1 *

Also Published As

Publication number Publication date
AUPQ008399A0 (en) 1999-05-27
WO2000064438A1 (en) 2000-11-02
CA2370553A1 (en) 2000-11-02
EP1173165A1 (en) 2002-01-23
JP2002542286A (en) 2002-12-10
HK1043546A1 (en) 2002-09-20
NZ513328A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
EP1217963A4 (en) Devices and methods for treating tissue
HK1043546A1 (en) Cardiovascular and bone treatment using isoflavones
HK1027986A1 (en) Method of sterilization
GB0110288D0 (en) Composition and treatment method
GB9920785D0 (en) Bone splint
HK1047250A1 (en) Tissue augmentation material and methods
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
GB9919482D0 (en) Waste treatment apparatus and methods
GB2361644B (en) Waste treatment apparatus and methods
IL146465A0 (en) Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
EP1027007A4 (en) Dental treatment methods
GB2370777B (en) Biodegradable tissue scafold and bone template
IL143990A0 (en) Bone stimulating factor
EP1194439A4 (en) Human eag2
IL133038A0 (en) Novel diagnosis and treatment for atherosclerosis
AU2638002A (en) Tissue treatment
GB9908993D0 (en) Treatment
GB9906710D0 (en) Game and apparatus
PL109436U1 (en) Therapeutic and rehabilitation table
GB9904918D0 (en) Skin treatment
GB9907649D0 (en) Skin treatment
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
TW371983U (en) Bone cabinet of fast and easy combination

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010912

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20010911;LT PAYMENT 20010911;LV PAYMENT 20010911;MK PAYMENT 20010911;RO PAYMENT 20010911;SI PAYMENT 20010911

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 9/00 B

Ipc: 7A 61K 35/78 B

Ipc: 7A 61K 31/352 A

Ipc: 7A 61P 19/10 B

Ipc: 7A 61P 9/10 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040330

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/352 20060101AFI20070226BHEP

Ipc: A61K 36/48 20060101ALI20070226BHEP

Ipc: A61P 19/10 20060101ALI20070226BHEP

Ipc: A61P 9/10 20060101ALI20070226BHEP

Ipc: A61P 9/00 20060101ALI20070226BHEP

Ipc: A23L 1/30 20060101ALI20070226BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070724

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1043546

Country of ref document: HK